相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus
Kamal M. F. Itani et al.
AMERICAN JOURNAL OF SURGERY (2010)
Comment on: Antibiotic stewardship-more education and regulation not more availability?
F. J. Cooke et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study)
Enno Jacobs et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria
A. J. Grisold et al.
JOURNAL OF INFECTION (2009)
Emerging Role of the Interleukin-8 Cleaving Enzyme SpyCEP in Clinical Streptococcus pyogenes Infection
Claire E. Turner et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
TRIMETHOPRIM-SULFAMETHOXAZOLE OR CLINDAMYCIN FOR TREATMENT OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS
David Y. Hyun et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci:: a Phase 3, multicentre, double-blind, randomized study
I. Florescu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
Dilip Nathwani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
MRSA carriage in healthcare personnel in contact with farm animals
M. W. H. Wulf et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2008)
High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S-aureus
S. Monecke et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections:: Reconsideration of empiric antimicrobial therapy
Samir S. Awad et al.
AMERICAN JOURNAL OF SURGERY (2007)
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus
Mary Jo Cenizal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients
Daniel J. Skiest et al.
JOURNAL OF INFECTION (2007)
Effect of antibiotics on Stahylococcus aureus producing Panton-Valentine leukocidin
Oana Dumitrescu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Dog bites
Marina Morgan et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S-aureus infection:: A prospective investigation
Loren G. Miller et al.
CLINICAL INFECTIOUS DISEASES (2007)
Necrotizing fasciitis: Case report and review of literature
L. Smeets et al.
ACTA CHIRURGICA BELGICA (2007)
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus
Dennis L. Stevens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004)
Gary J. Moet et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Nosocomial transmission of community-associated meticillin-resistant Staphylococcus aureus:: an emerging threat
Jonathan A. Otter et al.
LANCET INFECTIOUS DISEASES (2006)
Caiman bite
George Hertner
WILDERNESS & ENVIRONMENTAL MEDICINE (2006)
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Hajo Grundmann et al.
LANCET (2006)
Methicillin-resistant S-aureus infections among patients in the emergency department
Gregory J. Moran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Emergence of community-acquired methicillin-resistant Staphylococchus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections
MD King et al.
ANNALS OF INTERNAL MEDICINE (2006)
Practice guidelines for the diagnosis and management of skin and soft-tissue infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection
P Giordano et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Three-year surveillance of community-acquired Staphylococcus aureus infections in children
SL Kaplan et al.
CLINICAL INFECTIOUS DISEASES (2005)
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Community-acquired meticillin-resistant Staphylococcus aureus:: an emerging threat
N Zetola et al.
LANCET INFECTIOUS DISEASES (2005)
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus
JN Sharpe et al.
AMERICAN JOURNAL OF SURGERY (2005)
In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections
CE Edmiston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections
M Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate
BA Lipsky et al.
CLINICAL INFECTIOUS DISEASES (2004)
Complicated infections of skin and skin structures: when the infection is more than skin deep
MJ DiNubile et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection
TS Naimi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy
ME Jones et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments
DA Talan et al.
CLINICAL INFECTIOUS DISEASES (2003)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
DL Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
